Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details)

v2.4.0.8
Summary of Significant Accounting Policies (Details) (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Segment
Jun. 30, 2013
Dec. 31, 2013
Summary of Significant Accounting Policies [Line Items]          
Net Cash Provided by (Used in) Operating Activities     $ (44,541,000) $ (18,131,000)  
Net Cash Provided by (Used in) Financing Activities     (4,001,000) 163,785,000  
Goodwill and intangible assets 1,100,000,000   1,100,000,000   1,100,000,000
Amortization of intangible assets 2,826,000 2,688,000 5,569,000 5,402,000  
Revenue from services 2,153,000 3,188,000 4,123,000 6,280,000  
Revenue From Transfer Of Intellectual Property 0 2,015,000 476,000 14,772,000  
Total deferred revenue related to other revenues 8,300,000   8,300,000   8,300,000
Allowance for doubtful accounts receivable (1,547,000)   (1,547,000)   (1,885,000)
Equity-based compensation expense for continuing operations 3,400,000 1,800,000 6,993,000 7,003,000  
Number of reportable segments     2    
Pharmaceutical
         
Summary of Significant Accounting Policies [Line Items]          
Number of operating segments     2    
Diagnostics
         
Summary of Significant Accounting Policies [Line Items]          
Number of operating segments     2    
Neovasc
         
Summary of Significant Accounting Policies [Line Items]          
Revenue from services 100,000 200,000 100,000 400,000  
Minimum
         
Summary of Significant Accounting Policies [Line Items]          
Intangible assets, estimated useful lives     3 years    
Maximum
         
Summary of Significant Accounting Policies [Line Items]          
Intangible assets, estimated useful lives     10 years    
Restatement Adjustment
         
Summary of Significant Accounting Policies [Line Items]          
Net Cash Provided by (Used in) Operating Activities     (6,400,000) (2,500,000)  
Net Cash Provided by (Used in) Financing Activities     $ 6,400,000 $ 2,500,000